Ester Falconer Ab Cellera Biologics Inc. (ABCL) insider trading activity

ABCL Quotes by TradingView

Ester Falconer is Chief Technology Officer of AbCellera Biologics Inc.. Currently has a direct ownership of 875,000 shares of ABCL, which is worth approximately $2.49 Million. The most recent transaction as insider was on Sep 01, 2021, when has been sold 875,000 shares (Common Shares) at a price of $16.89 per share, resulting in proceeds of $14,778,749. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 875K
0% 3M change
0% 12M change
Total Value Held $2.49 Million

Ester Falconer Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 01 2021
BUY
Exercise of conversion of derivative security
$14,778,749 $16.89 p/Share
875,000 Added 50.0%
875,000 Common Shares
Jun 09 2021
SELL
Open market or private sale
$25,500,000 $25.5 p/Share
1,000,000 Reduced 100.0%
0 Common Shares
Mar 19 2021
BUY
Exercise of conversion of derivative security
$30,000 $0.03 p/Share
1,000,000 Added 50.0%
1,000,000 Common Shares
EF

Ester Falconer

Chief Technology Officer
Vancouver, A1

Track Institutional and Insider Activities on ABCL

Follow AbCellera Biologics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ABCL shares.

Notify only if

Insider Trading

Get notified when an Ab Cellera Biologics Inc. insider buys or sells ABCL shares.

Notify only if

News

Receive news related to AbCellera Biologics Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ABCL